Clin2
NCT07528235Possibly a fitNot yet recruiting

Propranolol infusion for preventing pneumonia after bleeding stroke

Intracerebral HemorrhageStroke-Associated Pneumonia (SAP)

Part of Brain & nervous system, Heart & circulation clinical trials.

This trial tests a drug called propranolol, usually used for blood pressure, to see if it can prevent a complication called SAP (stroke-associated pneumonia) in people who have had a bleeding stroke. The drug is given through an IV within 24 hours of stroke onset.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
30 people
Ages
10 years to 80 years
Study type
Interventional

Who can take part

  • You are between 18 and 80 years old.
  • You can start the study drug within 24 hours of stroke symptoms.
  • You have a bleeding stroke in the cerebrum (main part of the brain) with a clot size of at least 10 mL.
  • Your stroke is not caused by trauma, a tumor, or other specific conditions.
  • You have not had an infection in the last 4 weeks and have not taken antibiotics in the last 2 weeks.
  • You do not have certain heart or lung conditions, such as asthma, heart failure, or irregular heartbeat.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06863558Not yet recruiting· Phase 3
Early medication combination to reduce swelling after a brain bleed

This study tests whether giving a combination of blood-pressure-lowering medicines early after a brain bleed can reduce swelling and improve recovery. It aims to start treatment within 3 days of the bleed to see if it helps limit brain damage.

NCT06899464Not yet recruiting· Phase 4
Testing cerebrolysin for bleeding stroke within 6 hours

This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.

NCT07583147Not yet recruiting· Phase 2
Brain inflammation after bleeding stroke

This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.

Bordeaux
NCT03907046Recruiting· Phase 3
Blood thinner study to prevent stroke after brain bleed

This Phase 3 study tests whether a blood thinner (apixaban) can help prevent another stroke and support recovery after you’ve had a brain bleed. You would be assigned to a treatment group, and the study checks safety and whether strokes can be reduced without causing dangerous bleeding.

Birmingham, Alabama
NCT05460793Recruiting
Surgery timing trial for brain bleeding after a stroke

This trial looks at whether starting brain surgery within 8 hours after a type of stroke called intracerebral hemorrhage (bleeding in the brain) can improve outcomes. It’s for adults with a certain amount and location of bleeding and without common causes like an aneurysm or malformation.

Amsterdam
NCT07305896Not yet recruiting
Minocycline for bleeding in the brain

This trial tests whether an antibiotic called minocycline can help people who have had a bleeding stroke (intracerebral hemorrhage). The drug may reduce brain swelling and improve recovery. You must start treatment within 24 hours of the bleeding.

Hear when a new Intracerebral Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.